Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder

NCT05593796 | Unknown DMC

• 1 other identifier: 715715
• Study Type: interventional
• Target: 50
• Locations: 0 countries
• Sites: N/A

Brief Summary

The efficacy of cognitive behavioral therapy(CBT) in treatment of methamphetamine use disorder

Conditions

Methamphetamine Abuse

Outcome Measures

Primary Outcomes (1)

• increase in the addiction severity index for methamphetamine use disorder

  0-1 No imminent problem 2-3 slight problem 4-5 moderate problem 6-7considerable difficulty

  12 weeks

Study Arms (2)

treatment-as-usual (TAU)

ACTIVE COMPARATOR

Behavioral: cognitive behavioral therapy

Clinician-delivered CBT with tratment as usual

ACTIVE COMPARATOR

Behavioral: cognitive behavioral therapy

Interventions

cognitive behavioral therapy BEHAVIORAL

12 weekly, individual sessions of manual-guided CBT delivered by trained clinician .

Clinician-delivered CBT with tratment as usual; treatment-as-usual (TAU)

Eligibility Criteria

• Age: 15 Years - 50 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64)

You may qualify if:

• patients who meet the criteria for methamphetamine use disorder according to Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM 5) (10)
• aged of 15-49 years' old
• more than 9 year of education
• urine drug screening positive for methamphetamine

You may not qualify if:

• other Axis I disorder of DSM-V criteria such as bipolar disorder, schizophrenia, depression
• Had a legal case pending resulting in inability to commit to 12 weeks of treatment.
• Refusal to participate
• poly drug dependence.

Sponsors & Collaborators

• Assiut University: lead

MeSH Terms

Interventions

Cognitive Behavioral Therapy

Intervention Hierarchy (Ancestors)

Behavior Therapy; Psychotherapy; Behavioral Disciplines and Activities

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant lecture

Model Details: In phase 0: . These patients will undergo toxicological and psychiatric assessment and will be screened using the inclusion and exclusion criteria. phase 1: treatment-as-usual (TAU)- Group offered usual treatment include detoxification, medical care. Clinician-delivered CBT-Group offered 12 weekly, individual sessions of manual-guided CBT (15) delivered by trained clinician . phase2: a follow-up at 3-month post treatment phase without treatment.

Study Record Dates

• First Submitted: October 24, 2022
• First Posted: October 25, 2022
• Study Start: September 1, 2023
• Primary Completion: January 1, 2025
• Study Completion: March 1, 2025
• Last Updated: August 14, 2023

Record last verified: 2023-08